Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mahalingam

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Medicinal Chemistry|December 8, 2009
HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cellsA K Mahalingam, Linda Axelsson, Jenny K Ekegren, et al.
Journal of Medicinal Chemistry|November 28, 2006
Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationshipsXiongyu Wu, Yiqian Wan, A K Mahalingam, et al.
Bioorganic & Medicinal Chemistry|September 11, 2007
Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring systemA M S Murugaiah, Chalotta Wallinder, A K Mahalingam, et al.
Bioorganic & Medicinal Chemistry|May 25, 2010
Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibitionA K Mahalingam, Yiqian Wan, A M S Murugaiah, et al.
Journal of Medicinal Chemistry|March 5, 2004
First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivoYiqian Wan, Charlotta Wallinder, Berndt Johansson, et al.
Journal of Medicinal Chemistry|January 18, 2012
From the first selective non-peptide AT(2) receptor agonist to structurally related antagonistsA M S Murugaiah, Xiongyu Wu, Charlotta Wallinder, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonistYiqian Wan, Charlotta Wallinder, Bianca Plouffe, et al.
Trials|May 24, 2019
Rationale and protocol of the ENGAGE study: a double-blind randomized controlled preference trial using a comprehensive cohort design to measure the effect of a cognitive and leisure-based intervention in older adults with a memory complaintS Belleville, A Moussard, A I Ansaldo, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Medicinal Chemistry|December 8, 2009
HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cellsA K Mahalingam, Linda Axelsson, Jenny K Ekegren, et al.
Journal of Medicinal Chemistry|November 28, 2006
Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationshipsXiongyu Wu, Yiqian Wan, A K Mahalingam, et al.
Bioorganic & Medicinal Chemistry|September 11, 2007
Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring systemA M S Murugaiah, Chalotta Wallinder, A K Mahalingam, et al.
Bioorganic & Medicinal Chemistry|May 25, 2010
Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibitionA K Mahalingam, Yiqian Wan, A M S Murugaiah, et al.
Journal of Medicinal Chemistry|March 5, 2004
First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivoYiqian Wan, Charlotta Wallinder, Berndt Johansson, et al.
Journal of Medicinal Chemistry|January 18, 2012
From the first selective non-peptide AT(2) receptor agonist to structurally related antagonistsA M S Murugaiah, Xiongyu Wu, Charlotta Wallinder, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonistYiqian Wan, Charlotta Wallinder, Bianca Plouffe, et al.
Trials|May 24, 2019
Rationale and protocol of the ENGAGE study: a double-blind randomized controlled preference trial using a comprehensive cohort design to measure the effect of a cognitive and leisure-based intervention in older adults with a memory complaintS Belleville, A Moussard, A I Ansaldo, et al.
Pageof 2